Over the past five years, Gilead Sciences (NASDAQ: GILD) has generated an average annual return of 17.29%, outperforming the broader market by 5.62% on an annualized basis. An initial investment of $1,000 in Gilead stock five years ago would now be worth approximately $2,197.59.
Currently, Gilead Sciences has a market capitalization of $187.03 billion. The company’s stock performance reflects its position and growth within the pharmaceutical industry.
**Why this matters**
Understanding Gilead Sciences’ stock performance provides insight into its market resilience and investor confidence. For those considering long-term investments in the healthcare sector, Gilead’s returns highlight its potential as a strong performer relative to the overall market.
Source: NewsData